COVID-19 randomized controlled trials in medRxiv and PubMed
Author:
Funder
Pfizer
Publisher
Elsevier BV
Subject
Internal Medicine
Reference8 articles.
1. Kataoka Y., Oide S., Ariie T., Tsujimoto Y., Furukawa T.A.. Quality of COVID-19 research in preprints: a meta-epidemiological study protocol. protocols.io.2020. doi:10.17504/protocols.io.bhm8j49w.
2. Guidelines for reporting meta-epidemiological methodology research;Murad;Evid Based Med,2017
3. medRxiv COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv.https://connect.medrxiv.org/relate/content/181. Accessed July 3, 2020.
4. Keeping up with studies on covid-19: systematic search strategies and resources;Shokraneh;BMJ,2020
5. PubMed | Cochrane Work. https://work.cochrane.org/pubmed. Accessed June 3, 2020.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Impact of COVID-19 Pandemics on the Development of Health Risk Communication: Challenges and Opportunities;International Journal of Environmental Research and Public Health;2022-12-30
2. Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review;BMJ Medicine;2022-10
3. Transparency and reporting characteristics of COVID-19 randomized controlled trials;BMC Medicine;2022-09-26
4. From registration, protocol to report: are COVID-19-related RCTs in mainland China consistent? A systematic review of clinical trial registry and literature;BMJ Open;2022-07
5. Transparency and reporting characteristics of COVID-19 randomized controlled trials;2022-02-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3